Detection of AmpC β Lactamases in Gram-negative Bacteria
暂无分享,去创建一个
[1] A. Pandey,et al. Evaluation of phenotypic tests for the detection of AmpC beta-lactamase in clinical isolates of Escherichia coli. , 2013, Indian journal of pathology & microbiology.
[2] Jaspal Kaurthe. Increasing antimicrobial resistance and narrowing therapeutics in typhoidal salmonellae. , 2013, Journal of clinical and diagnostic research : JCDR.
[3] R. Laxminarayan,et al. Communicating trends in resistance using a drug resistance index , 2011, BMJ Open.
[4] Kenneth S. Thomson,et al. Extended-Spectrum-β-Lactamase, AmpC, and Carbapenemase Issues , 2010, Journal of Clinical Microbiology.
[5] R. Bonomo,et al. Three Decades of β-Lactamase Inhibitors , 2010, Clinical Microbiology Reviews.
[6] P. Coll,et al. A simple phenotypic method for differentiation between acquired and chromosomal AmpC beta-lactamases in Escherichia coli. , 2006, Enfermedades infecciosas y microbiologia clinica.
[7] N. Hanson. AmpC beta-lactamases: what do we need to know for the future? , 2003, The Journal of antimicrobial chemotherapy.
[8] N. Hanson,et al. Detection of Plasmid-Mediated AmpC β-Lactamase Genes in Clinical Isolates by Using Multiplex PCR , 2002, Journal of Clinical Microbiology.
[9] M. Ferraro. Performance standards for antimicrobial susceptibility testing , 2001 .
[10] G. Papanicolaou,et al. Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae , 1990, Antimicrobial Agents and Chemotherapy.